These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 8731673)

  • 1. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H; Heickendorff L; Søgaard H
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H; Søgaard H; Heickendorff L
    Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
    Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
    Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis.
    Kuijpers AL; van de Kerkhof PC
    Am J Clin Dermatol; 2000; 1(1):27-39. PubMed ID: 11702302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
    Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
    Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.